Loading clinical trials...

A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725 | Clinical Trials | Clareo Health

RECRUITINGPhase 1NCT06539507

A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725

This is a first-in-human, Phase 1/1b, 4-part study that includes the evaluation of safety, tolerability, pharmacokinetics (PK), and immunogenicity of BCX17725 when administered via single and multiple...

Lead sponsor: BioCryst Pharmaceuticals•5 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Contacts

BioCryst Pharmaceuticals, Inc.

CONTACT

+1 919 859 1302 clinicaltrials@biocryst.com

Related studies

Active Not RecruitingPhase 2/3

Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome

NCT05521438 · Netherton Syndrome

Not Yet Recruiting

Study of Skin and Gut Microbiome in a Skin Condition Involving Skin Barrier Impairment and Allergic Symptoms: Netherton Syndrome

NCT07280091 · Netherton Syndrome

COMPLETEDPhase 1/2

A Study to Evaluate Topically Applied SXR1096 Cream in Patients With Netherton Syndrome

NCT05211830 · Netherton Syndrome

COMPLETEDNA

Natural History and Biological Study of Netherton Syndrome

NCT02081313 · Netherton Syndrome, Healthy

TERMINATED

Natural History of Netherton Syndrome

NCT05902663 · Netherton Syndrome

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 31, 2026Terms

Trial snapshot

StatusRECRUITING

PhasePHASE1

Enrollment78

Start dateSep 2024

Last updatedMar 31, 2026

Condition

Netherton Syndrome

Locations shown

Stanford University School of Medicine

Palo Alto, California

Therapeutics Clinical Research

San Diego, California

Yale Center for Clinical Investigation

New Haven, Connecticut

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 31, 2026Data synced to Clareo: May 16, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions